Lexeo Therapeutics, Inc.
LXEO
Revenue
531.00k
▲531.00k∞%
-Assets
192.01M
▼-21.20M▼-9.94%
3 Months ChangeLiabilities
27.06M
▼-3.20M▼-10.56%
3 Months ChangeFree Cash Flow
-15.05M
▼-15.05M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0000950170-24-118569
2024-10-09
Form 8-K
ID: 0000950170-24-113764
2024-08-12
Form 10-Q
ID: 0000950170-24-095057
2024-08-12
Form 8-K
ID: 0000950170-24-095054
2024-07-15
Form 8-K
ID: 0000950170-24-083386
2024-07-08
Form 8-K
ID: 0000950170-24-081942
2024-06-28
Form 8-K
ID: 0000950170-24-078774
2024-05-09
Form 8-K
ID: 0000950170-24-056260
2024-05-09
Form 10-Q
ID: 0000950170-24-056247
2024-04-22
Form 8-K
ID: 0000950170-24-046197